M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
NeoGenomics completes acquisition of Pathline to expand Northeast US footprint
Cancer diagnostics company NeoGenomics Inc (NASDAQ:NEO) confirmed on Monday that it has completed its acquisition of Pathline LLC, a laboratory in New Jersey.
This acquisition enhances NeoGenomics' commercial presence in the Northeast United States and expands access to its oncology...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search